Overall, in metastatic melanoma, the PI3K pathway is altered by somatic mutations in a wide array of genes including PIK3CA, MTOR, PIK3R1, PIK3R5, and IRS4. This evidence concerns the gene PIK3R1 and metastatic melanoma.